Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:56 pm Sale | 2024-09-30 | 13G | Artiva Biotherapeutics, Inc. ARTV | venBio Global Strategic Fund III L.P. | 1,519,971 6.300% | -298,624 (-16.42%) | Filing History |
| 2024-09-03 4:18 pm Unchanged | 2024-08-29 | 13D | Artiva Biotherapeutics, Inc. ARTV | RA CAPITAL MANAGEMENT LLC | 9,853,302 40.600% | 0 (Unchanged) | Filing History |
| 2024-08-01 7:00 pm Purchase | 2024-07-22 | 13G | Artiva Biotherapeutics, Inc. ARTV | venBio Global Strategic Fund III L.P. | 1,818,595 7.800% | 1,818,595 (New Position) | Filing History |
| 2024-08-01 4:18 pm Purchase | 2024-07-22 | 13G | Artiva Biotherapeutics, Inc. ARTV | Venrock Healthcare Capital Partners III L.P. | 1,609,569 6.900% | 1,609,569 (New Position) | Filing History |
| 2024-08-01 4:17 pm Purchase | 2024-07-22 | 13G | Artiva Biotherapeutics, Inc. ARTV | 5AM Ventures VI L.P. | 2,353,304 10.100% | 2,353,304 (New Position) | Filing History |
| 2024-07-29 4:29 pm Purchase | 2024-07-22 | 13D | Artiva Biotherapeutics, Inc. ARTV | RA CAPITAL MANAGEMENT LLC | 9,853,302 42.300% | 9,853,302 (New Position) | Filing History |
| 2024-07-29 4:15 pm Purchase | 2024-07-22 | 13D | Artiva Biotherapeutics, Inc. ARTV | GC Corp. | 4,567,412 19.600% | 4,567,412 (New Position) | Filing History |